Professor
JONGPIL KIM, Ph.D.
Professor/ Distinguished Professor
Dept. of Chemistry
Director, Institute for Stem Cells & Regenerative Medicine
연구소장, 생체분자화학연구소 (교육부 지원 대학중점연구소)
E-mail jpkim153@dongguk.edu or jk2316@gmail.com

 

 


Academic & Research Background

 
Postdoctoral Associate, MIT, Whitehead Institute, Cambridge, USA (2008-2012), Advisor: Rudolf Jaenisch
Ph.D, Columbia University, Biochemistry & Neurobiology, New York, USA (2008) 
M.S,  Gwangju Institute of Science and Technology, Life Science, Gwangju,KOREA(2001)

B.S,   DONGGUK UNIVERSITY, SEOUL, KOREA (1999) 


Professor, Dept. of Chemistry, Dongguk Univ. (2012-Present)

Honors & Awards
 
2023    Dongguk Excellent Researcher 선정
2021   동국 학술상
2020   과학기술인상(한국연구재단)
2019   동국 학술상
2018   동국 우수 연구자상
2017   자랑스러운 동국인상
2015   Outstanding Research Award, Dongguk University
2013   Best Teaching Award, Dongguk University
2008   The Brunie Prize in Stem Cell Research, Columbia University
1994   Scholarship for Excellent Student, Dongguk University

Selective Publications

1. Single-cell RNA-sequencing identifies disease-associated oligodendrocytes in male APP NL-G-F and 5XFAD mice. Hanseul Park, Byounggook Cho, Hongwon Kim, Takashi Saito, Takaomi C Saido, Kyoung-Jae Won, Jongpil Kim,(Corresponding author), Nature Communications, 2023, Feb 15, 2023 (IF:17.6)

 

2. Dormant state of quiescent neural stem cells links Shank3 mutation to autism development.  Hongwon Kim, Byounggook Cho, Hanseul Park, Junyeop Kim, Siyoung Kim, Jaein Shin, Christopher J Lengner, Kyoung Jae Won,  Jongpil Kim, (Corresponding author), Molecular Psychiatry, 2022, 20 April 2022 (IF: 15.9)

 

3.Electromagnetized graphene facilitates direct lineage reprogramming into dopaminergic neurons. Yujung Chang; Junsang Yoo; Junyeop Kim; Yerim Hwang; Gayong Shim; Yu-Kyoung Oh; Jongpil Kim,(Corresponding author), Advanced Functional Materials, 12 August 2021, 2105346, (IF: 18.8)

 

4. In vivo neuronal gene editing via CRISPR-Cas9 amphiphilic nanocomplexes alleviates deficits in mouse models of Alzheimer’s disease. Park H,Oh J,Shim G,Cho B,Chang Y,Kim S,Baek S,Kim H,Shin J,Choi H,Yoo J,Kim J,Jun W,Lee M,Lengner C,Oh YK, Kim J.(Corresponding author), Nature Neuroscience, 2019 Apr;22(4):524-528. (IF: 20.7)

 

5. Modeling G2019S-LRRK2 Sproadic Parkinson’s disease in 3D Midbrain organoids. Kim H, Park HJ, Choi H, Chang Y, Park H, Shin J, Kim J, Lengner CJ, Lee YK, Kim J. (Corresponding author), Stem Cell Reports. 2019 Mar 5;12(3):518 -531. (IF: 7.7)

 

6. Electromagnetized gold nanoparticles mediated direct lineage reprogramming into induced dopamine neurons in vivo for Parkinson’s disease therapy. Yoo J, Lee E, Jung J, Kim J, Chang Y, Park G, Baek S, Jang W, Kwon Y, Kim S, Lengner C, Kim J,(Corresponding author), Nature Nanotechnology,2017,12, p1006–1014, (IF: 39.2)

 

7. Modeling Apolipoprotein E ε3/4 allele-associated sporadic Alzheimer’s disease in an induced neuron. Kim H, Yoo J, Shin J, Chang J, JungJ,JoDG,KimJ,JangW,LengnerCJ, KimB,and Kim J. (Corresponding author) Brain, 2017 Aug 1;140(8):2193-2209. (IF: 13.5)

 

8. Electromagnetic fields mediate efficient cell reprogramming into a pluripotent state. Baek S, Quan X, Kim S, Lengner C, Park JK, Kim J. (Corresponding author), ACS Nano,2014 Oct 28;8(10):10125-38. (IF: 15.8)

 

9. Functional integration of dopaminergic neurons directly converted from mouse fibroblasts. Kim J, Su SC, Wang H, Cheng AW, Cassady JP, Lodato MA, Lengner CJ, Chung CY, Dawlaty MM, Tsai LH, Jaenisch R.(First author), Cell Stem Cell. 2011 Nov 4;9(5):413-9. (IF: 20.8)

 

10. A MicroRNA feedback circuit in midbrain dopamine neurons. Kim J, Inoue K, Ishii J, Vanti WB, Voronov SV, Murchison E, Hannon G, Abeliovich A., (First author), Science. 2008 Aug 31;317(5842):1220-4. (IF: 41.8)